GlassScriptPhysician profile
Stephanie Chow
NPI 1356738744
$2,218.45
in general payments reported to CMS, 2019-2025
15 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Gynecologic Oncology provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2021: $60.30 · 2022: $1,304 · 2023: $74.23 · 2024: $323 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $743.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $743.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,179.19 | 2022-2024 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $268.68 | 2022-2025 | Lynparza |
| Abbvie INC. | $161.06 | 2025 | |
| Sk Life Science, INC. | $157.07 | 2024 | |
| Tesaro, INC. | $111.29 | 2019 | |
| Myriad Genetic Laboratories, INC. | $98.65 | 2021-2024 | Myrisk |
| Coherus Oncology, INC. | $44.89 | 2022-2023 | |
| Daiichi Sankyo INC. | $43.55 | 2022-2025 | Injectafer |
| Lilly USA, LLC | $28.26 | 2024 | Verzenio, Retevmo, Jaypirca |
| Eisai INC. | $25.77 | 2024 | |
| Novartis Pharmaceuticals Corporation | $23.45 | 2025 | |
| Hologic Sales and Service, LLC | $20.78 | 2024 | Coolseal Generator |
| Aadi Bioscience, INC. | $20.22 | 2024 | Fyarro |
| Springworks Therapeutics, INC. | $20.07 | 2025 | Ogsiveo |
| Abbott Laboratories | $15.52 | 2024 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.